Jefferies Downgrades Tango Therapeutics Inc. (TNGX) to Hold

May 14, 2026 2:53 AM

Jefferies analyst Maury Raycroft downgraded Tango Therapeutics Inc. (NASDAQ: TNGX) from Buy to Hold with a price target of $27.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found